UC Davis Infectious Disease Expert Available to Comment on COVID-19 following President’s Diagnosis

Dean Blumberg, M.D., is chief of pediatric infectious diseases at UC Davis Children’s Hospital. He has spoken about COVID-19 on NBC Nightly News, NPR, and various additional media outlets. He is involved in clinical vaccine research and childhood immunization policies.…

New intranasal vaccine platform provides potential for more effective vaccines with fewer side effects

A new study at the University of Chicago and Duke University finds that a new type of intranasal vaccine induces a strong immune response in lungs, with possible implications for COVID-19. The system uses nanofibers tagged with antigens to prime the immune system against a potential invasion.